THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
Thrombocytopenia in patients with chronic hepatitis C virus (HCV) infection is a major problem. The pathophysiology is multifactorial, with auto-immunogenicity, direct bone marrow suppression, hypersplenism, decreased production of thrombopoietin and therapeutic adverse effect all contributing to th...
Main Authors: | Sumit Dahal, Smrity Upadhyay, Rashmi Banjade, Prajwal Dhakal, Navin Khanal, Vijaya Raj Bhatt |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2017-03-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/2835 |
Similar Items
-
Danazol one Month Treatment of Thrombocytopenia in Chronic Hepatitis C
by: Hosam Dawod, et al.
Published: (2016-03-01) -
Conventional Versus Pegylated Interferons in Treatment of HCV Patients
by: M Amirbigi, et al.
Published: (2012-04-01) -
Clinical significance blood platelet count in patients with chronic hepatitis C on the background of the various options combined antiviral therapy
by: K. V. Zhdanov, et al.
Published: (2014-09-01) -
Hepatitis C virus-associated thrombocytopenia is not related to serum thrombopoietin levels
by: Afifi Ola, et al.
Published: (2007-01-01) -
Treatment Related Hematologic Changes in a Population of Iranian Patients with Chronic Hepatitis C Infection from 2009 to 2014
by: Zahra AHMADINEJAD, et al.
Published: (2017-10-01)